O'Malley RE - Search Results

Year	Number of Results
1982	1
1983	1
1985	1
1991	1
1997	1
1998	1
1999	1
2005	1
2011	1
2014	1
2015	1
2016	2
2017	1
2018	2
2019	2
2020	1
2021	1
2022	1
2024	0

1

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Mintz-Hittner HA, et al. N Engl J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374. N Engl J Med. 2011. PMID: 21323540 Free PMC article. Clinical Trial.

2

Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy.

Wykoff CC, Nittala MG, Villanueva Boone C, Yu HJ, Fan W, Velaga SB, Ehlers JP, Ip MS, Sadda SR; RECOVERY Study Group. Wykoff CC, et al. Ophthalmol Retina. 2022 Jul;6(7):557-566. doi: 10.1016/j.oret.2022.02.013. Epub 2022 Mar 5. Ophthalmol Retina. 2022. PMID: 35257962 Clinical Trial.

3

Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema.

Payne JF, Clark WL, Bruce BB, Wykoff CC, Brown DM, Menke BM, Iverson SM, Allen KF, Boyer DS; Treat & Extend Protocol in Patients with Diabetic Macular Edema Study Group. Payne JF, et al. Ophthalmology. 2018 Aug;125(8):1304-1306. doi: 10.1016/j.ophtha.2018.03.046. Epub 2018 May 3. Ophthalmology. 2018. PMID: 29729809 Clinical Trial. No abstract available.

4

Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results.

Payne JF, Wykoff CC, Clark WL, Bruce BB, Boyer DS, Brown DM; TREX-DME Study Group. Payne JF, et al. Br J Ophthalmol. 2021 Feb;105(2):253-257. doi: 10.1136/bjophthalmol-2020-316176. Epub 2020 Apr 17. Br J Ophthalmol. 2021. PMID: 32303499 Clinical Trial.

5

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.

Wykoff CC, Nittala MG, Zhou B, Fan W, Velaga SB, Lampen SIR, Rusakevich AM, Ehlers JP, Babiuch A, Brown DM, Ip MS, Sadda SR; Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy Study Group. Wykoff CC, et al. Ophthalmol Retina. 2019 Dec;3(12):1076-1086. doi: 10.1016/j.oret.2019.07.011. Epub 2019 Jul 24. Ophthalmol Retina. 2019. PMID: 31542339 Clinical Trial.

6

Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial.

Abdelfattah NS, Hariri AH, Al-Sheikh M, Pitetta S, Ebraheem A, Wykoff CC, Sadda SR; TREX-AMD Study Group. Abdelfattah NS, et al. Am J Ophthalmol. 2018 Aug;192:84-90. doi: 10.1016/j.ajo.2018.05.008. Epub 2018 May 12. Am J Ophthalmol. 2018. PMID: 29763612 Clinical Trial.

7

Dynamic intraocular pressure measurements during vitrectomy.

Moorhead LC, Gardner TW, Lambert HM, O'Malley RE, Willis AW, Meharg LS, Moorhead WD. Moorhead LC, et al. Among authors: o malley re. Arch Ophthalmol. 2005 Nov;123(11):1514-23. doi: 10.1001/archopht.123.11.1514. Arch Ophthalmol. 2005. PMID: 16286613

8

Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results.

Wykoff CC, Croft DE, Brown DM, Wang R, Payne JF, Clark L, Abdelfattah NS, Sadda SR; TREX-AMD Study Group. Wykoff CC, et al. Ophthalmology. 2015 Dec;122(12):2514-22. doi: 10.1016/j.ophtha.2015.08.009. Epub 2015 Sep 29. Ophthalmology. 2015. PMID: 26391465 Free article. Clinical Trial.

9

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.

Payne JF, Wykoff CC, Clark WL, Bruce BB, Boyer DS, Brown DM; TREX-DME Study Group. Payne JF, et al. Am J Ophthalmol. 2019 Jun;202:91-99. doi: 10.1016/j.ajo.2019.02.005. Epub 2019 Feb 14. Am J Ophthalmol. 2019. PMID: 30771333 Clinical Trial.

10

Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.

Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, Tawansy KA, Mintz-Hittner HA; BEAT-ROP Cooperative Group. Geloneck MM, et al. JAMA Ophthalmol. 2014 Nov;132(11):1327-33. doi: 10.1001/jamaophthalmol.2014.2772. JAMA Ophthalmol. 2014. PMID: 25103848 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year